Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Bone Marrow Transplantation|March 30, 2001
Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breast cancer treated with high-dose chemotherapy and stem cell transplantationC Solano, B Badia, A Lluch, et al.Bone Marrow Transplantation|June 26, 1999
Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC)I Benet, B F Prosper, I Marugan, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 10, 2005
Guillain-Barré syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantationJ-C Hernández-Boluda, M-J Lis, R Goterris, et al.The Journal of Experimental Medicine|March 23, 2000
Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xLM Horita, E J Andreu, A Benito, et al.British Journal of Haematology|November 28, 2001
Ex vivo expansion of umbilical cord blood (UCB) CD34(+) cells alters the expression and function of alpha 4 beta 1 and alpha 5 beta 1 integrinsM Ramírez, J C Segovia, I Benet, et al.Bone Marrow Transplantation|August 23, 2005
Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizersR Goterris, J C Hernández-Boluda, A Teruel, et al.Leukemia|February 20, 2003
Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapyF Prósper, C Solá, J Hornedo, et al.Leukemia|March 10, 2001
Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamideP Menéndez, F Prósper, C Bueno, et al.Sangre|August 1, 1994
[Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes]J García Marco, A Miguel Sosa, J García Conde, et al.Bone Marrow Transplantation|June 13, 2000
Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndromeJ A Martínez-Climent, A M Comes, E Vizcarra, et al.Pageof 3